title: Aspalatone, a new antiplatelet agent, attenuates the neurotoxicity induced by kainic acid in the rat.
abstract: The antioxidant efficacy of aspalatone (APT; acetyl salicylic acid maltol ester), a new antiplatelet agent, has been characterized in vivo as well as in vitro, and several observations indicated that the antioxidant could prevent the neuroexcitation caused by oxidative stress. In this report, the effect of APT was evaluated on kainic acid (KA)-induced neurotoxicity, since the neurotoxicity induced by KA is, at least in part, mediated via the formation of free radicals. The results showed that pretreatments with APT or maltol (MAL) significantly attenuated seizure activity, oxidative stress (lipid peroxidation and protein oxidation) and the loss of hippocampal neurons induced by KA. On the other hand, the pretreatments with aspirin (ASP), ASP together with MAL or vitamin E failed to protect against the toxicity produced by KA suggesting that the mechanism of action for APT on the KA-induced neurotoxicity is different from that of ASP. These finding raise the possibility that salicylmaltol, a metabolite of APT, plays a role in preventing the neurotoxicity evoked by KA. Therefore, our results suggest that an APT-related antioxidant mechanism, which is linked to the MAL moiety, is involved in the neuroprotective effect against KA.
authors.affiliation: Department of Pharmacy, College of Pharmacy, Kangwon National University, Chunchon, Korea.
authors.forename: H C
authors.initials: HC
authors.lastname: Kim
authors.forename: D Y
authors.initials: DY
authors.lastname: Choi
authors.forename: W K
authors.initials: WK
authors.lastname: Jhoo
authors.forename: D W
authors.initials: DW
authors.lastname: Lee
authors.forename: C H
authors.initials: CH
authors.lastname: Koo
authors.forename: C
authors.initials: C
authors.lastname: Kim
mesh_terms: D000818:Animals; D001241:Aspirin / Q000031:analogs & derivatives* / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000473:pathology; D007608:Kainic Acid / Q000633:toxicity*; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D018696:Neuroprotective Agents / Q000494:pharmacology*; D018384:Oxidative Stress; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D018696:Neuroprotective Agents; D010975:Platelet Aggregation Inhibitors; C091320:aspalatone; D001241:Aspirin; D007608:Kainic Acid